Milacemide
| Names | |
|---|---|
| IUPAC name
N2-Pentylglycinamide | |
| Systematic IUPAC name
2-(Pentylamino)acetamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| MeSH | milacemide |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C7H16N2O | |
| Molar mass | 144.218 g·mol−1 |
| log P | 0.754 |
| Related compounds | |
Related compounds |
Tricine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Milacemide (INN) is an MAO-B inhibitor and glycine prodrug. It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease. Early clinical trials did not show positive results however, and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.